Tiratricol Treatment of Children With Monocarboxylate Transporter 8 Deficiency: Triac Trial II
Latest Information Update: 25 Jun 2024
At a glance
- Drugs Tiratricol (Primary)
- Indications Allan-Herndon-Dudley syndrome
- Focus Registrational; Therapeutic Use
- Acronyms Triac Trial II
- Sponsors Rare Thyroid Therapeutics
- 19 Jun 2024 According to Egetis media release, data will be presented at a forthcoming medical meeting, submitted to a peer-reviewed medical journal and shared with regulatory authorities. Results from Triac Trial II and will be included in the response to EMA 120-day list of questions in August 2024.
- 19 Jun 2024 Results published in a Egetis media release
- 19 Jun 2024 Primary endpoint has not been met (Bayley Scales of Infant Development III Gross Motor Skill Domain score) , according to Egetis media release